349 related articles for article (PubMed ID: 26279360)
1. Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases.
Egwuagu CE; Yu CR; Sun L; Wang R
Cytokine Growth Factor Rev; 2015 Oct; 26(5):587-93. PubMed ID: 26279360
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Regulatory B Cells in Experimental Autoimmune Uveitis.
Choi JK; Egwuagu CE
Methods Mol Biol; 2021; 2270():437-450. PubMed ID: 33479912
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 35 Regulatory B Cells.
Choi JK; Egwuagu CE
J Mol Biol; 2021 Jan; 433(1):166607. PubMed ID: 32755620
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 35-Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases.
Egwuagu CE; Yu CR
Crit Rev Immunol; 2015; 35(1):49-57. PubMed ID: 25746047
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 35-Producing Exosomes Suppress Neuroinflammation and Autoimmune Uveitis.
Kang M; Choi JK; Jittayasothorn Y; Egwuagu CE
Front Immunol; 2020; 11():1051. PubMed ID: 32547555
[TBL] [Abstract][Full Text] [Related]
6. IL-27-producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases.
Choi JK; Yu CR; Bing SJ; Jittayasothorn Y; Mattapallil MJ; Kang M; Park SB; Lee HS; Dong L; Shi G; Caspi RR; Egwuagu CE
Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34782464
[TBL] [Abstract][Full Text] [Related]
7. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
8. Production of IL-35 by Bregs is mediated through binding of BATF-IRF-4-IRF-8 complex to il12a and ebi3 promoter elements.
Yu CR; Choi JK; Uche AN; Egwuagu CE
J Leukoc Biol; 2018 Dec; 104(6):1147-1157. PubMed ID: 30117603
[TBL] [Abstract][Full Text] [Related]
9. The Immunobiology of Interleukin-35 and Its Regulation and Gene Expression.
Song M; Ma X
Adv Exp Med Biol; 2016; 941():213-225. PubMed ID: 27734415
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-35 is a critical regulator of immunity during helminth infections associated with multiple sclerosis.
Correale J; Marrodan M; Carnero Contentti E
Immunology; 2021 Nov; 164(3):569-586. PubMed ID: 34197631
[TBL] [Abstract][Full Text] [Related]
11. The possible role of interleukin-35 and its therapeutic potential in pemphigus.
Tavakolpour S; Kheiry F; Mirsafaei HS; Akhlaghdoust M
Int Immunopharmacol; 2017 Jan; 42():11-17. PubMed ID: 27855302
[TBL] [Abstract][Full Text] [Related]
12. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
[TBL] [Abstract][Full Text] [Related]
13. IL-35 and Autoimmunity: a Comprehensive Perspective.
Choi J; Leung PS; Bowlus C; Gershwin ME
Clin Rev Allergy Immunol; 2015 Dec; 49(3):327-32. PubMed ID: 25619872
[TBL] [Abstract][Full Text] [Related]
14. MTB driven B cells producing IL-35 and secreting high level of IL-10 in the patients with active pulmonary tuberculosis.
Dai YC; Wang WD; Zhang JA; Chen C; Luo HL; Xu H; Peng Y; Luo H; Yang XR; Chen X; Wu XJ; Chen GH; Chen ZW; Xu JF
Mol Immunol; 2019 Aug; 112():175-181. PubMed ID: 31170628
[TBL] [Abstract][Full Text] [Related]
15. IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease.
Dambuza IM; He C; Choi JK; Yu CR; Wang R; Mattapallil MJ; Wingfield PT; Caspi RR; Egwuagu CE
Nat Commun; 2017 Sep; 8(1):719. PubMed ID: 28959012
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy.
Quan S; Sheng JR; Abraham PM; Soliven B
Clin Exp Immunol; 2016 Apr; 184(1):50-61. PubMed ID: 26671281
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease.
Sun L; He C; Nair L; Yeung J; Egwuagu CE
Cytokine; 2015 Oct; 75(2):249-55. PubMed ID: 25796985
[TBL] [Abstract][Full Text] [Related]
18. Regulatory B cells in ANCA-associated vasculitis.
Wilde B; Thewissen M; Damoiseaux J; Knippenberg S; Hilhorst M; van Paassen P; Witzke O; Cohen Tervaert JW
Ann Rheum Dis; 2013 Aug; 72(8):1416-9. PubMed ID: 23666929
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer cell-derived IL-35 promotes tumor progression via induction of IL-35-producing induced regulatory T cells.
Hao S; Chen X; Wang F; Shao Q; Liu J; Zhao H; Yuan C; Ren H; Mao H
Carcinogenesis; 2018 Dec; 39(12):1488-1496. PubMed ID: 30321288
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory cytokine interleukin-35 and immune thrombocytopaenia.
Zhu JJ; Shan NN
J Int Med Res; 2020 Dec; 48(12):300060520976477. PubMed ID: 33356722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
